Altaf Bhat

Prof. Altaf Bhat


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
ZFZeenat Farooq
Zeenat Farooq
SBShahid Banday
Shahid Banday
TPTej K. Pandita
Tej K. Pandita
ABAltaf Bhat
Altaf Bhat

1 September 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SBShahid Banday
Shahid Banday
ZFZeenat Farooq
Zeenat Farooq
RRRomana Rashid
Romana Rashid
EAEhsaan Abdullah
Ehsaan Abdullah
ABAltaf Bhat
Altaf Bhat
Heterochromatin in the fission yeast Schizosaccharomyces pombe is clustered at the nuclear periphery and interacts with a number of nuclear membrane proteins. However, the significance and the factors that sequester heterochromatin at the nuclear periphery are not fully known. Here, we report that an inner nuclear membrane protein complex Lem2-Nur1 is essential for heterochromatin-mediated gene silencing. We found that Lem2 is physically associated with another inner nuclear membrane protein, Nur1, and deletion of either lem2 or nur1 causes silencing defect at centromeres, telomeres, and rDNA loci. We analyzed the genome-wide association of Lem2 using ChIP sequencing and we found that it binds to the central core region of centromeres, in striking contrast to Chp1, a component of pericentromeric heterochromatin, which binds H3K9me-rich chromatin in neighboring sequences. The recruitment of Lem2 and Nur1 to silent regions of the genome is dependent on H3K9 methyltransferase, Clr4. Finally, we show that the Lem2-Nur1 complex regulates the local balance between the underln]Snf2/HDAC-containing repressor complex (SHREC) histone deacetylase complex and the anti-silencing protein Epe1. These findings uncover a novel role for Lem2-Nur1 as a key functional link between localization at the nuclear periphery and heterochromatin-mediated gene silencing.

1 October 2016 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SGShabir Ganai
Shabir Ganai
SBShahid Banday
Shahid Banday
ZFZeenat Farooq
Zeenat Farooq
ABAltaf Bhat
Altaf Bhat

11 July 2018 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SGShabir Ganai
Shabir Ganai
ZFZeenat Farooq
Zeenat Farooq
SBShahid Banday
Shahid Banday
ABAltaf Bhat
Altaf Bhat
Aim: Aberrant activity of class I histone deacetylases (HDACs) has strong implications for various cancers. Targeting these HDACs with synthetic HDAC inhibitors has shown significant side effects such as atrial fibrillation and QT prolongation emphasizing the need of natural inhibitors as substitutes to synthetic ones. Results: The binding propensity of the two plant-derived inhibitors apigenin and luteolin towards class I HDAC isoforms was checked using extra-precision molecular docking and implicit solvation MMGBSA. Apigenin showed a superior binding affinity against these isoforms as compared to luteolin. Both inhibitors docked stable to the binding pocket of these HDACs as determined by molecular dynamics simulation study. Conclusion: Apigenin and luteolin may serve as substitutes to synthetic inhibitors for effective HDAC based anticancer therapy.

29 June 2021 in Genes
Verified
Journal Article
Open access
PDF file
AMArjamand Mushtaq
Arjamand Mushtaq
UMUlfat Syed Mir
Ulfat Syed Mir
CHClayton R. Hunt
Clayton R. Hunt
SPShruti Pandita
Shruti Pandita
WTWajahat W. Tantray
Wajahat W. Tantray
Tej Krishan PanditaTej Krishan Pandita
Tej Krishan Pandita
Packaging of the eukaryotic genome with histone and other proteins forms a chromatin structure that regulates the outcome of all DNA mediated processes. The cellular pathways that ensure genomic stability detect and repair DNA damage through mechanisms that are critically dependent upon chromatin structures established by histones and, particularly upon transient histone post-translational modifications. Though subjected to a range of modifications, histone methylation is especially crucial for DNA damage repair, as the methylated histones often form platforms for subsequent repair protein binding at damaged sites. In this review, we highlight and discuss how histone methylation impacts the maintenance of genome integrity through effects related to DNA repair and repair pathway choice.

9 November 2017 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
SGShabir Ganai
Shabir Ganai
EAEhsaan Abdullah
Ehsaan Abdullah
RRRomana Rashid
Romana Rashid
ABAltaf Bhat
Altaf Bhat
Histone deacetylases (HDACs) regulate epigenetic gene expression programs by modulating chromatin architecture and are required for neuronal development. Dysregulation of HDACs and aberrant chromatin acetylation homeostasis have been implicated in various diseases ranging from cancer to neurodegenerative disorders. Histone deacetylase inhibitors (HDACi), the small molecules interfering HDACs have shown enhanced acetylation of the genome and are gaining great attention as potent drugs for treating cancer and neurodegeneration. HDAC2 overexpression has implications in decreasing dendrite spine density, synaptic plasticity and in triggering neurodegenerative signalling. Pharmacological intervention against HDAC2 though promising also targets neuroprotective HDAC1 due to high sequence identity (94%) with former in catalytic domain, culminating in debilitating off-target effects and creating hindrance in the defined intervention. This emphasizes the need of designing HDAC2-selective inhibitors to overcome these vicious effects and for escalating the therapeutic efficacy. Here we report a top-down combinatorial in silico approach for identifying the structural variants that are substantial for interactions against HDAC1 and HDAC2 enzymes. We used extra-precision (XP)-molecular docking, Molecular Mechanics Generalized Born Surface Area (MMGBSA) for predicting affinity of inhibitors against the HDAC1 and HDAC2 enzymes. Importantly, we employed a novel in silico strategy of coupling the state-of-the-art molecular dynamics simulation (MDS) to energetically-optimized structure based pharmacophores (e-Pharmacophores) method via MDS trajectory clustering for hypothesizing the e-Pharmacophore models. Further, we performed e-Pharmacophores based virtual screening against phase database containing millions of compounds. We validated the data by performing the molecular docking and MM-GBSA studies for the selected hits among the retrieved ones. Our studies attributed inhibitor potency to the ability of forming multiple interactions and infirm potency to least interactions. Moreover, our studies delineated that a single HDAC inhibitor portrays differential features against HDAC1 and HDAC2 enzymes. The high affinity and selective HDAC2 inhibitors retrieved through e-Pharmacophores based virtual screening will play a critical role in ameliorating neurodegenerative signalling without hampering the neuroprotective isoform (HDAC1).